Primary care patient characteristics associated with completion of 6-month buprenorphine treatment

Addictive Behaviors

Volumn 38, Issue 11, 2013, Pages 2724-2728

  Neumann, Anne M ^a   Blondell, Richard D ^a   Azadfard, Mohammadreza ^a   Nathan, Ganon ^a   Homish, Gregory G ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Buprenorphine; Opioid addiction; Opioid dependence; Patient characteristics; Primary care; Treatment retention

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; COUNSELING; DEMOGRAPHY; DRUG DOSE INCREASE; FEMALE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

BUPRENORPHINE; OPIOID ADDICTION; OPIOID DEPENDENCE; PATIENT CHARACTERISTICS; PRIMARY CARE; TREATMENT RETENTION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; BUPRENORPHINE; COUNSELING; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84882568464     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.07.007     Document Type: Article

References (26)

1. Alford D.P., LaBelle C.T., Kretsch N., Bergeron A., Winter M., Botticelli M. Collaborative care of opioid-addicted patients in primary care using buprenorphine. Archives of Internal Medicine 2011, 171:425-431.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Press, Washington, DC.
3. Barry D.T., Irwin K.S., Jones E.S., Becker W.C., Tetrault J.M., Sullivan L.E., Fiellin D.A. Integrating buprenorphine treatment into office-based practice: A qualitative study. Journal of General Internal Medicine 2009, 24(2):218-225.
4. Blondell R.D., Ashrafioun L., Dambra C.M., Foschio E.M., Zielinski A.L., Salcedo D.M. A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and coexistent opioid addiction. Journal of Addiction Medicine 2010, 4(3):140-146.
5. Fiellin D.A., Barry D.T., Sullivan L.E., Cutter C.J., Moore B.A., O'Connor P.G., Schottenfeld R.S. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. The American Journal of Medicine 2013, 126(1):74.e11-74.e17.
6. Fiellin D.A., Moore B.A., Sullivan L.E., Becker W.C., Pantalon M.V., Chawarski M.C., Schottenfeld R.S. Long-term treatment with buprenorphine/naloxone in primary care: Results at 2-5years. The American Journal on Addictions 2008, 17:116-120.
7. Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.E., O'Connor P.G., Schottenfeld R.S. Counseling plus buprenorphine-naloxone maintenance therapy of opioid dependence. The New England Journal of Medicine 2006, 355(4):365-374.
8. Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., Tusel D. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. The New England Journal of Medicine 2003, 349(10):949-958.
9. Haddad M.S., Zelenev A., Altice F.L. Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes. Drug and Alcohol Dependence 2013, 10.1016/j.drugalcdep.2012.12.008.
10. Johnson R.E., Strain E.C., Amass L. Buprenorphine: How to use it right. Drug and Alcohol Dependence 2003, 70(2 Suppl.):S59-S77.
11. Kakko J., Svanborg K.D., Kreek M.J., Heilig M. 1-Year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial. Lancet 2003, 361:662-668.
12. Kochanek K.D., Xu J., Murphy S.L., Miniño A.M., Kung H.C. Deaths: Final data for 2009. National vital statistics reports 2011, 60(3).
13. Moore B.A., Barry D.T., Sullivan L.E., O'Connor P.G., Cutter C.J., Schottenfeld R.S., Fiellin D.A. Counseling and directly observed medication for primary care buprenorphine maintenance: A pilot study. Journal of Addiction Medicine 2012, 6(3):205-211.
14. Moore B.A., Fiellin D.A., Barry D.T., Sullivan L.E., Chawarski M.C., O'Connor P.G., Schottenfeld R.S. Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine 2007, 22:527-530.
15. National Center of Injury Prevention and Control Policy impact: Prescription painkiller overdoses. Center for Diseases Control and Prevention 2011.
16. Neumann A.M., Blondell R.D., Jaanimägi U., Giambrone A.K., Homish G.G., Lozano J.R., Azadfard M. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and co-existent opioid addiction. Journal of Addictive Diseases 2013, 32:68-78.
17. Pade P.A., Cardon K.E., Hoffman R.M., Geppert C.M.A. Prescription opioid abuse, chronic pain, and primary care: A co-occurring disorders clinic in the chronic disease model. Journal of Substance Abuse Treatment 2012, 43(4):446-450.
18. Parran T.V., Adelman C.A., Merkin B., Pagano M.E., Defranco R., Ionescu R.A., Mace A.G. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug and Alcohol Dependence 2010, 106:56-60.
19. Paulozzi L.J., Jones C.M., Mack K.A., Rudd R.A. Vital signs: Overdoses of prescription opioid pain relievers - United States, 1999-2008. Morbidity and Mortality Weekly Report 2011, 60(43):1487-1492.
20. Ren J., Ning Z., Asche C.V., Zhuang M., Kirkness C.S., Ye X., Pan Q. Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005-2011. Current Medical Research & Opinion 2013, 29(7):1-8.
21. Schottenfeld R.S., Pakes J.R., Kosten T.R. Prognostic factors in buprenorphine- versus methadone-maintained patients. The Journal of Nervous & Mental Disease 1998, 186(1):35-43.
22. Soeffing J.M., Martin L.D., Fingerhood M.I., Jasinski D.R., Rastegar D.A. Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1year. Journal of Substance Abuse Treatment 2009, 37(4):426-430.
23. Stein M.D., Cioe P., Friedmann P.D. Brief report: Buprenorphine retention in primary care. Journal of General Internal Medicine 2005, 20:1038-1041.
24. Substance Abuse and Mental Health Administration Medication-assisted treatment for opioid addiction in opioid treatment programs 2005.
25. Substance Abuse and Mental Health Administration Results from the 2010 National Survey on Drug Use and Health: Summary of national findings 2011, Health and Human Services, Rockville, MD.
26. Sullivan L.E., Moore B.A., O'Connor P.G., Barry D.T., Chawarski M.C., Schottenfeld R.S., Fiellin D.A. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. The American Journal on Addictions 2009, 19:53-58.